Reardon Andrew (CIK 0001950232)

Latest company ownership

LGND - LIGAND PHARMACEUTICALS INC
Role: CLO & Secretary
Shares held
30,811
Last filed at
Aug 12, 2025
Confidence Score
43.7
2025Q4
Confidence Score History
2022Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 10, 2025 Aug 12, 2025 LIGAND PHARMACEUTICALS INC CLO & Secretary Sell 22.5 -1,325 -4.12% ✗ $198.8K
Jun 30, 2025 Jul 2, 2025 LIGAND PHARMACEUTICALS INC CLO & Secretary Buy 68.8 +233 0.73% ✗ $21.2K
Jun 23, 2025 Jun 24, 2025 LIGAND PHARMACEUTICALS INC CLO & Secretary Sell 22.5 -500 -1.54% ✗ $57K
Jun 10, 2025 Jun 12, 2025 LIGAND PHARMACEUTICALS INC CLO & Secretary Sell 22.5 -500 -1.52% ✗ $57.3K
Aug 10, 2024 Jun 2, 2025 LIGAND PHARMACEUTICALS INC CLO & Secretary Sell 22.5 -1,897 -3.36% ✗ $193.8K
Feb 14, 2025 Feb 19, 2025 LIGAND PHARMACEUTICALS INC CLO & Secretary Sell 97.5 +5,834 25.89% ✗ $782.8K
Sep 23, 2024 Sep 25, 2024 LIGAND PHARMACEUTICALS INC CLO & Secretary Sell 22.5 -2,000 -8.15% ✗ $199.2K
Aug 28, 2024 Aug 30, 2024 LIGAND PHARMACEUTICALS INC CLO & Secretary Sell 22.5 -1,500 -6.24% ✗ $159.6K
Jun 28, 2024 Jul 2, 2024 LIGAND PHARMACEUTICALS INC Chief Legal Officer & Buy 78.8 +329 1.48% ✗ $20K
May 9, 2024 May 13, 2024 LIGAND PHARMACEUTICALS INC Chief Legal Officer & Sell 20.0 -10,000 -31.05% ✗ $830.4K
Feb 15, 2024 Feb 16, 2024 LIGAND PHARMACEUTICALS INC CHIEF LEGAL OFFICER & Sell 26.3 -593 -3.80% ✗ $44.3K
Dec 29, 2023 Jan 4, 2024 LIGAND PHARMACEUTICALS INC CHIEF LEGAL OFFICER & Buy 78.8 +179 1.16% ✗ $10.9K
Aug 10, 2023 Aug 14, 2023 LIGAND PHARMACEUTICALS INC CHIEF LEGAL OFFICER & Sell 22.5 -897 -5.50% ✗ $61.7K
Mar 24, 2023 Mar 28, 2023 LIGAND PHARMACEUTICALS INC Officer Sell 26.3 -300 -1.81% ✗ $21K
Nov 30, 2022 Dec 1, 2022 LIGAND PHARMACEUTICALS INC Officer Sell 22.5 -1,073 -8.93% ✗ $78.2K